The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 26 | 51.2x | 20.1x | Below average | |
Growth | 83 | 23.1% | 5.6% | Above average | |
Quality | 77 | 18.4% | 7.6% | Above average | |
Safety | 87 | -1.7x | 0.4x | Above average | |
Capital Return | 35 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Cellebrite DI Ltd. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Cellebrite DI Ltd. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Recent analyst reviews for Cellebrite stock have shown positive stability with a slight tilt toward optimism, as the average price target increased by 0.41% over the past 30 days to reach 19.75 dollars. This stability reflects analyst confidence in the company's financial performance, especially with a notable price gap (Upside) between the current price (14.98 dollars) and the lowest observed price target (15 dollars), indicating limited downside risk from the analysts' perspective.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.